OrganoClick AB Statistics

Total Valuation

OrganoClick AB has a market cap or net worth of SEK 77.22 million. The enterprise value is 165.13 million.

Market Cap	77.22M
Enterprise Value	165.13M

Important Dates

The last earnings date was Wednesday, April 8, 2026.

Earnings Date	Apr 8, 2026
Ex-Dividend Date	n/a

Share Statistics

OrganoClick AB has 110.00 million shares outstanding. The number of shares has increased by 3.92% in one year.

Current Share Class	110.00M
Shares Outstanding	110.00M
Shares Change (YoY)	+3.92%
Shares Change (QoQ)	+8.71%
Owned by Insiders (%)	39.36%
Owned by Institutions (%)	14.49%
Float	46.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.73
PB Ratio	3.78
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.54
EV / Sales	1.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.71

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 4.18.

Current Ratio	0.45
Quick Ratio	0.15
Debt / Equity	4.18
Debt / EBITDA	n/a
Debt / FCF	-8.12
Interest Coverage	-3.73

Financial Efficiency

Return on equity (ROE) is -130.50% and return on invested capital (ROIC) is -15.48%.

Return on Equity (ROE)	-130.50%
Return on Assets (ROA)	-11.98%
Return on Invested Capital (ROIC)	-15.48%
Return on Capital Employed (ROCE)	-56.74%
Weighted Average Cost of Capital (WACC)	8.09%
Revenue Per Employee	2.72M
Profits Per Employee	-932,590
Employee Count	39
Asset Turnover	0.81
Inventory Turnover	3.07

Taxes

Income Tax	-293,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -68.09% in the last 52 weeks. The beta is 1.07, so OrganoClick AB's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	-68.09%
50-Day Moving Average	1.23
200-Day Moving Average	1.62
Relative Strength Index (RSI)	36.95
Average Volume (20 Days)	639,383

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OrganoClick AB had revenue of SEK 106.19 million and -36.37 million in losses. Loss per share was -0.36.

Revenue	106.19M
Gross Profit	20.76M
Operating Income	-25.14M
Pretax Income	-38.29M
Net Income	-36.37M
EBITDA	-19.20M
EBIT	-25.14M
Loss Per Share	-0.36

Full Income Statement

Balance Sheet

The company has 2.68 million in cash and 85.36 million in debt, giving a net cash position of -82.68 million or -0.75 per share.

Cash & Cash Equivalents	2.68M
Total Debt	85.36M
Net Cash	-82.68M
Net Cash Per Share	-0.75
Equity (Book Value)	20.41M
Book Value Per Share	0.14
Working Capital	-49.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.29 million and capital expenditures -2.22 million, giving a free cash flow of -10.51 million.

Operating Cash Flow	-8.29M
Capital Expenditures	-2.22M
Depreciation & Amortization	5.94M
Net Borrowing	1.24M
Free Cash Flow	-10.51M
FCF Per Share	-0.10

Full Cash Flow Statement

Margins

Gross margin is 19.55%, with operating and profit margins of -23.67% and -34.25%.

Gross Margin	19.55%
Operating Margin	-23.67%
Pretax Margin	-36.06%
Profit Margin	-34.25%
EBITDA Margin	-18.08%
EBIT Margin	-23.67%
FCF Margin	n/a

Dividends & Yields

OrganoClick AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.92%
Shareholder Yield	-3.92%
Earnings Yield	-47.10%
FCF Yield	-13.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OrganoClick AB has an Altman Z-Score of -2.43 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.43
Piotroski F-Score	1